Sansheng Guojian announced that in the contract dispute arbitration case involving the company as the respondent, the applicant changed the arbitration request, involving a total amount of 507 million yuan, accounting for 5.66% of the company's total assets audited at the end of 2025. Currently, the case has been tried in court, no ruling has been made, and there is still uncertainty about the impact on the company's profits. Fujian Pharmaceutical, the controlling shareholder of the company, promised that if the company were to assume any payment obligations, it would bear the full amount.

Sansheng Guojian announced that in the contract dispute arbitration case involving the company as the respondent, the applicant changed the arbitration request, involving a total amount of 507 million yuan, accounting for 5.66% of the company's total assets audited at the end of 2025. Currently, the case has been tried in court, no ruling has been made, and there is still uncertainty about the impact on the company's profits. Fujian Pharmaceutical, the controlling shareholder of the company, promised that if the company were to assume any payment obligations, it would bear the full amount.